An interventional study of Paro Robot in Pediatric ALL, Child, Hospitalized and Physical Therapy Modalities, sponsored by University of Nebraska. Completed at 1 site in United States. Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-10-28.
Sponsored by University of Nebraska · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Precursor Cell Lymphoblastic Leukemia-Lymphoma by University of Nebraska — none open to participants now, none under way, none of them phase 3. Precursor Cell Lymphoblastic Leukemia-Lymphoma · University of Nebraska.
Among the 12 studies in Precursor Cell Lymphoblastic Leukemia-Lymphoma by University of Nebraska, this one is the only one that started in 2022, is one of 2 with no phase, and was the 12th registered.
2,586 studies on the registry are indexed under Precursor Cell Lymphoblastic Leukemia-Lymphoma; 471 are open to participants now.
Browse Precursor Cell Lymphoblastic Leukemia-Lymphoma studies →None of the 12 studies in Precursor Cell Lymphoblastic Leukemia-Lymphoma by University of Nebraska is open now. The open studies under Precursor Cell Lymphoblastic Leukemia-Lymphoma, anywhere →
Of the 369 Precursor Cell Lymphoblastic Leukemia-Lymphoma studies recruiting now, 96 (26%) set no upper age limit and 257 (70%) stop at 75 or younger; 247 take children under 18; 29 take healthy volunteers.
This study: 5 Years to 18 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 7
First in 1995; this study’s year is marked. 1 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 51 is above the median of 40 across 1,953 interventional studies indexed under Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Median enrollment 30 across the 9 interventional studies, 40 across the 3 observational. Of the 11 that completed or were terminated, 7 (64%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Nebraska is the lead sponsor of 496 studies on the registry; 66 are open to participants now.
Of its 83 completed or terminated interventional studies of FDA-regulated products, 53 (64%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 12 studies in Precursor Cell Lymphoblastic Leukemia-Lymphoma by University of Nebraska, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to:
Aim 1: Evaluate the feasibility [consent and refusal rates, attrition rates, length, and number of completed therapy sessions], and acceptability [interviews with children and guardians, overall patient and guardian satisfaction] during inpatient physical therapy (PT) and occupational therapy (OT) sessions. Hypothesis: Animal-assisted interaction (AAI) with Paro, a robotic baby harp seal, during pediatric inpatient PT/OT sessions will be feasible and acceptable.
Aim 2: Assess preliminary efficacy of AAI during PT/OT sessions with Paro on behavior (anxiety and affect) and motivation to participate in rehabilitation in hospitalized children. Hypothesis: Children who use Paro will demonstrate less anxiety, more positive affect, and greater motivation to participate in therapy than those who do not use Paro.
Aim 3: Test the stress, anxiety, and depression levels of parents/guardians of children who use Paro inpatient physical and occupational therapy sessions. Hypothesis: In addition, parents and guardians of children that use Paro will report less stress, anxiety, and depression compared to parents/guardians of children that do not use Paro.
Animal Assisted Interactions (AAIs) are interventions that intentionally incorporate animals as part of a therapeutic process to promote human health, learning, and well-being. In general, domestic and farm animals such as dogs, cats, birds, equines, guinea pigs, rabbits, llamas, sheep, goats, and pigs are predominantly featured in AAI programs. Animals can be observed, held, and petted, or more actively integrated into specific therapy activities such as brushing with different tools to encourage range of motion and fine motor coordination. AAIs also promote exercise through tandem walking with the animals. Recent literature indicates that AAI can improve reality orientation and attention span, eliminate the sense of isolation, reduce stress and anxiety, enhance communication, promote positive social interactions, and enhance overall quality of life. The use of AAI in hospitalized children has the potential to engage patients, family members, and healthcare staff in an innovative, holistic approach to recovery.
While additional research is warranted to further explore the potential impact of AAI on a variety of clinically meaningful patient outcomes, the highly technical, fast-paced hospital environment and the immunocompromised health statuses of many acutely ill hospitalized patients greatly limit the exploration of AAI in inpatient settings. A new frontier in animal robotics opens a vast array of opportunities to implement AAI in hospitalized populations. Robot animals may be just as effective as live animals and may provide even more flexibility and tailoring to meet the needs of diverse situations that arise in the hospital. In addition, the infection control risk that live animals pose to hospitalized patients may be significantly lessened.
For this study, the investigators plan to conduct a two-armed randomized controlled trial with repeated measures. Hospitalized pediatric patients will participate in semi-structured, prescriptive physical and occupational therapy sessions on the categories of: 1) speech; 2) balance and endurance; 3) memory; 4) self-esteem; 5) fine motor; 6) sensory stimulation. Intervention group subjects (n=30) will participate in 10-30 minute therapy sessions with Paro, a therapeutic robotic baby harp seal. Control group subjects (n=30) will participate in 10-30 minute therapy sessions without Paro.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
10-30 minute semi-structured, prescriptive therapy sessions with Paro robot focused on the categories of 1) speech; 2) balance and endurance; 3) memory; 4) self-esteem; 5) fine motor; 6) sensory stimulation
Device: Paro Robot
10-30 minute semi-structured, prescriptive therapy sessions without Paro robot focused on the categories of 1) speech; 2) balance and endurance; 3) memory; 4) self-esteem; 5) fine motor; 6) sensory stimulation
Parents/guardians of hospitalized children who are assigned to the following arm "Physical and Occupational Therapy with Paro Robot"
Device: Paro Robot
Parents/guardians of hospitalized children who are assigned to the following arm "Physical and Occupational Therapy with out Paro Robot"
Device: PARO therapy seal PARO, a baby harp seal, is an advanced interactive, therapeutic medical robot developed by AIST, a leading Japanese industrial automation pioneer. It allows the documented benefits of animal therapy to be administered to patients in environments such as hospitals and extended care facilities where live animals present treatment or logistical difficulties.
Pain: Wrong-Baker FACES Pain Rating Scale
The scale shows a series of faces ranging from a happy face at 0 which represents "no hurt" to a crying face at 10 which represents "hurts worst." Based on the faces and descriptions, the patient chooses the face that best describes their level of pain.
Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Anxiety: Children's Anxiety Meter-State (CAM-S)
The Children's Anxiety Meter-State (CAM-S) scale is a visual drawing used to measure anxiety in children. It is drawn to resemble a thermometer with a bulb at the bottom and horizontal lines at intervals going up to the top. The child is instructed to indicate with a line how they are feeling. The bottom of the thermometer minimum number is 0, which represents not worried or not nervous with anxiety increasing as it goes to the top of the thermometer with a max number of 10, representing very worried or very nervous.
Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Intervention Acceptability
Patient Satisfaction Measure: Investigator-developed Satisfaction Measure contains one item which asks the participants to rank their satisfaction with the intervention from 1-5 (1 being not at all satisfied and 5 being very much satisfied)
Time frame: Assessed within 1 week following the participant's final (up to 4th) therapy session
Number of Hospital Acquired Infections-Central Line Associated Blood Stream Infections (CLABSI)
A count of Central Line Associated Blood Stream Infections (CLABSI) will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.
Time frame: Data collected starting from time of enrollment in the study until one week post last therapy session.
Number of Hospital Acquired Infections-Catheter-Associated Urinary Tract Infections (CAUTI)
A count of Catheter-Associated Urinary Tract Infections (CAUTI) will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.
Time frame: Data collected starting from time of enrollment in the study until one week post last therapy session.
Number of Hospital Acquired Infections-Enteroviruses
A count of Enteroviruses infections will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.
Time frame: Data collected starting from time of enrollment in the study until one week post last therapy session.
Number of Hospital Acquired Infections-Influenza
A count of Influenza infections will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.
Time frame: Data collected starting from time of enrollment in the study until one week post last therapy session.
Number of Hospital Acquired Infections-Multi-Drug Resistant Organisms
A count of Multi-Drug Resistant Organism infections will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.
Time frame: Data collected starting from time of enrollment in the study until one week post last therapy session.
Number of Hospital Acquired Infections-Surgical-Site Infections (SSI)
A count of Surgical-Site Infections (SSI) will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.
Time frame: Data collected starting from time of enrollment in the study until one week post last therapy session.
Number of Hospital Acquired Infections Ventilator-Associated Pneumonia (VAP)
A count of Ventilator-Associated Pneumonia (VAP) infections will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.
Time frame: Data collected starting from time of enrollment in the study until one week post last therapy session.
Total Number of Participants With Sedation Exposure
Sedative and analgesic medications will be abstracted from the electronic medical record (EMR) in order to calculate sedation frequency for 4 hours after each PT/OT session in which PARO was used.
Time frame: 4 hours after each of the 4 individual session
Microbial Contamination Screening of PARO Robot Seal
The ATP Monitoring with SystemSURE Plus Process uses a process which monitors levels of ATP Bioluminescence. The investigators will implement established cleaning protocols on the robot seal and then measure ATP after the PT/OT session by swabbing PARO on the following areas: head, right flipper, left flipper, bottom \[by on/off switch\], top left back area, top right back area, stomach \[underneath\].This measure outcome is reporting the percentage of how many screenings and subsequent cleanings were completed on the seal. Since this was a requirement, 100% of the screenings and subsequent cleanings were complete.
Time frame: Once, immediately after the participant completed all study therapy sessions
Activity Performance Form- Time of Session
The Activity Performance Form is an investigator developed measure that assesses the length of each therapy session (in minutes), the time to the patient's first out of bed movement, as well as the number and types of range of motion exercises performed (Passive, Active assist, and Active). This measure is for time of session.
Time frame: Immediately after each of the 4 individual session
Activity Performance Form- Range of Motion Exercises
The Activity Performance Form is an investigator developed measure that assesses the length of each therapy session (in minutes), the time to the patient's first out of bed movement, as well as the number and types of range of motion exercises performed (Passive, Active assist, and Active). This measure is for range of motion.
Time frame: Assessed at each of up to 4 therapy sessions; values represent the sum across all sessions attended for each participant.
Physiologic Variables-Blood Pressure
Blood Pressure (systolic \& diastolic)
Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Physiologic Variables-Respiratory Rate
Respiratory Rate
Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Physiologic Variables- Oxygen Saturation
Oxygen Saturation
Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Physiologic Variable- Heart Rate
Heart Rate
Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Opinion on Pets
18-item instrument with seven-point Likert scale (1-strongly disagree to 7-strongly agreed) designed to measure the favorableness of attitudes toward pets. Minimum Score = 18; Maximum score = 126. The higher the score, the more favorable a patient feels towards pets.
Time frame: Prior to the start of the first therapy session.
Parent/Guardian Stress- Total Difficultly
42-item instrument with a five-point Likert scale designed to measure stress in parents whose child has a chronic illness or requires prolonged medical monitoring. It includes four domains or subscales. Minimum Score = 42; Maximum Score = 210. Higher scores indicate higher stress.
Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Parent/Guardian Anxiety
Parent/Guardian anxiety and depressive symptoms as measured by the Hospital Anxiety and Depression Scale (HADS). Two sub-scales (Anxiety \& Depression) scored separately. Minimum Score = 0; Maximum Score = 21. Higher score = higher anxiety and/or depression. This measure is for the anxiety score.
Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Parent/Guardian Depression
Parent/Guardian anxiety and depressive symptoms as measured by the Hospital Anxiety and Depression Scale (HADS). Two sub-scales (Anxiety \& Depression) scored separately. Minimum Score = 0; Maximum Score = 21. Higher score = higher anxiety and/or depression. This measure is for the depression score.
Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Mood/Affect
The PANAS-10 is a 10-item instrument that asks the child to rate adjectives of varying mood states according to how often the child feels joyful, cheerful, happy, lively, proud, miserable, mad, afraid, scared, and sad. The item response uses a five-point Likert scale ranging from 1 ('very slightly or none at all') to 5 ('extremely'). The instrument yields two subscales: Positive Affect (joyful, cheerful, happy, lively, proud) and Negative Affect (miserable, mad, afraid, scared, sad), each summed from 5 items. Each subscale ranges from a minimum of 5 to a maximum of 25. Higher scores on the Positive Affect subscale indicate more positive affect (a better outcome). Higher scores on the Negative Affect subscale indicate more negative affect (a worse outcome).
Time frame: Change from pre-session to post-session, averaged across up to 4 therapy sessions completed during the hospital stay.
Change in Motivation to Participate in Therapy
The Pediatric Motivation Scale for Rehabilitation is a 19-item scale with a six-point smiley-face response format (1 = not true at all to 6 = definitely true) that measures motivation from a child's perspective, assessed after each therapy session. It has six subscales: Effort/Importance, Interest/Enjoyment, Competence, Relatedness, Autonomy, and Value/Usefulness. Negatively worded items are reverse-scored prior to analysis. Each subscale score is the average of its items, ranging from 1 to 6, with higher scores indicating a higher level of that concept (a more favorable outcome). Values reported represent the change in each subscale score from the participant's first therapy session to their last therapy session attended.
Time frame: Change from the participant's first therapy session to their last therapy session attended (up to 4 sessions).
| Milestone | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot | Parents/Guardians of Hospitalized Children Who Use Paro Robot | Parents/Guardians of Hospitalized Children Who do Not Use Paro Robot |
|---|---|---|---|---|
| Started | 12 | 14 | 12 | 13 |
| Completed | 12 | 14 | 12 | 13 |
| Not completed | 0 | 0 | 0 | 0 |
The scale shows a series of faces ranging from a happy face at 0 which represents "no hurt" to a crying face at 10 which represents "hurts worst." Based on the faces and descriptions, the patient chooses the face that best describes their level of pain.
| units on a scale | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot |
|---|---|---|
| Pain: Wrong-Baker FACES Pain Rating Scale | -0.17 ± 1.51 | 0.15 ± 2.38 |
The Children's Anxiety Meter-State (CAM-S) scale is a visual drawing used to measure anxiety in children. It is drawn to resemble a thermometer with a bulb at the bottom and horizontal lines at intervals going up to the top. The child is instructed to indicate with a line how they are feeling. The bottom of the thermometer minimum number is 0, which represents not worried or not nervous with anxiety increasing as it goes to the top of the thermometer with a max number of 10, representing very worried or very nervous.
| units on a scale | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot |
|---|---|---|
| Anxiety: Children's Anxiety Meter-State (CAM-S) | 0.21 ± 0.75 | 0.025 ± 2.46 |
Patient Satisfaction Measure: Investigator-developed Satisfaction Measure contains one item which asks the participants to rank their satisfaction with the intervention from 1-5 (1 being not at all satisfied and 5 being very much satisfied)
| units on a scale | Physical and Occupational Therapy With Paro Robot |
|---|---|
| Intervention Acceptability | 5 ± 0 |
A count of Central Line Associated Blood Stream Infections (CLABSI) will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.
| Infections | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot |
|---|---|---|
| Number of Hospital Acquired Infections-Central Line Associated Blood Stream Infections (CLABSI) | 0 | 1 |
A count of Catheter-Associated Urinary Tract Infections (CAUTI) will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.
| Infections | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot |
|---|---|---|
| Number of Hospital Acquired Infections-Catheter-Associated Urinary Tract Infections (CAUTI) | 0 | 0 |
A count of Enteroviruses infections will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.
| Infections | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot |
|---|---|---|
| Number of Hospital Acquired Infections-Enteroviruses | 0 | 1 |
A count of Influenza infections will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.
| Infections | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot |
|---|---|---|
| Number of Hospital Acquired Infections-Influenza | 0 | 0 |
A count of Multi-Drug Resistant Organism infections will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.
| Infections | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot |
|---|---|---|
| Number of Hospital Acquired Infections-Multi-Drug Resistant Organisms | 0 | 0 |
A count of Surgical-Site Infections (SSI) will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.
| Infections | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot |
|---|---|---|
| Number of Hospital Acquired Infections-Surgical-Site Infections (SSI) | 0 | 0 |
A count of Ventilator-Associated Pneumonia (VAP) infections will be collected from the electronic medical record. The total number of infections will be counted for the group as a whole. This is represented by a number of infections within that group.
| Infections | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot |
|---|---|---|
| Number of Hospital Acquired Infections Ventilator-Associated Pneumonia (VAP) | 0 | 0 |
Sedative and analgesic medications will be abstracted from the electronic medical record (EMR) in order to calculate sedation frequency for 4 hours after each PT/OT session in which PARO was used.
| Participants | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot |
|---|---|---|
| Total Number of Participants With Sedation Exposure | 2 | 1 |
The ATP Monitoring with SystemSURE Plus Process uses a process which monitors levels of ATP Bioluminescence. The investigators will implement established cleaning protocols on the robot seal and then measure ATP after the PT/OT session by swabbing PARO on the following areas: head, right flipper, left flipper, bottom \[by on/off switch\], top left back area, top right back area, stomach \[underneath\].This measure outcome is reporting the percentage of how many screenings and subsequent cleanings were completed on the seal. Since this was a requirement, 100% of the screenings and subsequent cleanings were complete.
| percentage of screenings completed | Physical and Occupational Therapy With Paro Robot |
|---|---|
| Microbial Contamination Screening of PARO Robot Seal | 100 |
The Activity Performance Form is an investigator developed measure that assesses the length of each therapy session (in minutes), the time to the patient's first out of bed movement, as well as the number and types of range of motion exercises performed (Passive, Active assist, and Active). This measure is for time of session.
| minutes | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot |
|---|---|---|
| Activity Performance Form- Time of Session | 30.03 ± 7.23 | 32.83 ± 12.80 |
The Activity Performance Form is an investigator developed measure that assesses the length of each therapy session (in minutes), the time to the patient's first out of bed movement, as well as the number and types of range of motion exercises performed (Passive, Active assist, and Active). This measure is for range of motion.
| Exercises | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot |
|---|---|---|
| Active Range of Motion | 84 | 87 |
| Active Assist Range of Motion | 11 | 20 |
Blood Pressure (systolic \& diastolic)
| mmHg | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot |
|---|---|---|
| Systolic Change | -2.55 ± 9.69 | 2.94 ± 13.58 |
| Diastolic Change | -0.96 ± 10.96 | 6.91 ± 11.98 |
Respiratory Rate
| respirations per minute | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot |
|---|---|---|
| Physiologic Variables-Respiratory Rate | -0.7 ± 4.33 | -0.8 ± 4.49 |
Oxygen Saturation
| percentage of oxygen saturation | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot |
|---|---|---|
| Physiologic Variables- Oxygen Saturation | -0.55 ± 3.15 | -0.43 ± 2.97 |
Heart Rate
| beats per minute | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot |
|---|---|---|
| Physiologic Variable- Heart Rate | 2.23 ± 17.28 | 1.61 ± 12.19 |
18-item instrument with seven-point Likert scale (1-strongly disagree to 7-strongly agreed) designed to measure the favorableness of attitudes toward pets. Minimum Score = 18; Maximum score = 126. The higher the score, the more favorable a patient feels towards pets.
| units on a scale | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot |
|---|---|---|
| Opinion on Pets | 110.56 ± 8.20 | 105.46 ± 19.14 |
42-item instrument with a five-point Likert scale designed to measure stress in parents whose child has a chronic illness or requires prolonged medical monitoring. It includes four domains or subscales. Minimum Score = 42; Maximum Score = 210. Higher scores indicate higher stress.
| units on a scale | Parents/Guardians of Hospitalized Children Who Use Paro Robot | Parents/Guardians of Hospitalized Children Who do Not Use Paro Robot |
|---|---|---|
| Parent/Guardian Stress- Total Difficultly | -12.22 ± 19.06 | -1.71 ± 20.81 |
Parent/Guardian anxiety and depressive symptoms as measured by the Hospital Anxiety and Depression Scale (HADS). Two sub-scales (Anxiety \& Depression) scored separately. Minimum Score = 0; Maximum Score = 21. Higher score = higher anxiety and/or depression. This measure is for the anxiety score.
| units on a scale | Parents/Guardians of Hospitalized Children Who Use Paro Robot | Parents/Guardians of Hospitalized Children Who do Not Use Paro Robot |
|---|---|---|
| Parent/Guardian Anxiety | -1.9 ± 4.38 | -1 ± 3.97 |
Parent/Guardian anxiety and depressive symptoms as measured by the Hospital Anxiety and Depression Scale (HADS). Two sub-scales (Anxiety \& Depression) scored separately. Minimum Score = 0; Maximum Score = 21. Higher score = higher anxiety and/or depression. This measure is for the depression score.
| units on a scale | Parents/Guardians of Hospitalized Children Who Use Paro Robot | Parents/Guardians of Hospitalized Children Who do Not Use Paro Robot |
|---|---|---|
| Parent/Guardian Depression | -0.7 ± 2.21 | -0.27 ± 2.8 |
The PANAS-10 is a 10-item instrument that asks the child to rate adjectives of varying mood states according to how often the child feels joyful, cheerful, happy, lively, proud, miserable, mad, afraid, scared, and sad. The item response uses a five-point Likert scale ranging from 1 ('very slightly or none at all') to 5 ('extremely'). The instrument yields two subscales: Positive Affect (joyful, cheerful, happy, lively, proud) and Negative Affect (miserable, mad, afraid, scared, sad), each summed from 5 items. Each subscale ranges from a minimum of 5 to a maximum of 25. Higher scores on the Positive Affect subscale indicate more positive affect (a better outcome). Higher scores on the Negative Affect subscale indicate more negative affect (a worse outcome).
| units on a scale | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot |
|---|---|---|
| Positive Affect | 1.93 ± 3.74 | 0.93 ± 4.36 |
| Negative Affect | -0.29 ± 2.7 | -0.91 ± 2.1 |
The Pediatric Motivation Scale for Rehabilitation is a 19-item scale with a six-point smiley-face response format (1 = not true at all to 6 = definitely true) that measures motivation from a child's perspective, assessed after each therapy session. It has six subscales: Effort/Importance, Interest/Enjoyment, Competence, Relatedness, Autonomy, and Value/Usefulness. Negatively worded items are reverse-scored prior to analysis. Each subscale score is the average of its items, ranging from 1 to 6, with higher scores indicating a higher level of that concept (a more favorable outcome). Values reported represent the change in each subscale score from the participant's first therapy session to their last therapy session attended.
| units on a scale | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot |
|---|---|---|
| Effort Importance Subscale | -0.15 ± .88 | 0.15 ± 0.5 |
| Interest Enjoyment Subscale | 0.33 ± 0.81 | 0.39 ± 1.05 |
| Competence Subscale | 0.46 ± 1.05 | 0.5 ± 0.78 |
| Relatedness Subscale | 0.15 ± 0.84 | 0.63 ± 1.45 |
| Autonomy Subscale | 0.33 ± 0.76 | -0.35 ± 1.6 |
| Value Usefulness Subscale | -0.15 ± 0.85 | 0.41 ± 0.76 |
Collected over From enrollment until end of last therapy session, up to 4 session over 4 weeks. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Physical and Occupational Therapy With Paro Robot | 0/12 (0%) | 0/12 (0%) | 0/12 (0%) |
| Physical and Occupational Therapy Without Paro Robot | 0/14 (0%) | 0/14 (0%) | 0/14 (0%) |
| Parents/Guardians of Hospitalized Children Who Use Paro Robot | 0/12 (0%) | 0/12 (0%) | 0/12 (0%) |
| Parents/Guardians of Hospitalized Children Who do Not Use Paro Robot | 0/13 (0%) | 0/13 (0%) | 0/13 (0%) |
| Age, Categorical(Participants) | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot | Parents/Guardians of Hospitalized Children Who Use Paro Robot | Parents/Guardians of Hospitalized Children Who do Not Use Paro Robot | Total |
|---|---|---|---|---|---|
| <=18 years | 12 | 14 | 0 | 0 | 26 |
| Between 18 and 65 years | 0 | 0 | 12 | 13 | 25 |
| >=65 years | 0 | 0 | 0 | 0 | 0 |
| Age, Continuous(years) | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot | Parents/Guardians of Hospitalized Children Who Use Paro Robot | Parents/Guardians of Hospitalized Children Who do Not Use Paro Robot | Total |
|---|---|---|---|---|---|
| Mean | 8.75 ± 3.745 | 8.64 ± 2.790 | 41.25 ± 6.566 | 35.77 ± 6.234 | 23.25 ± 15.89 |
| Sex: Female, Male(Participants) | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot | Parents/Guardians of Hospitalized Children Who Use Paro Robot | Parents/Guardians of Hospitalized Children Who do Not Use Paro Robot | Total |
|---|---|---|---|---|---|
| Female | 9 | 8 | 12 | 13 | 42 |
| Male | 3 | 6 | 0 | 0 | 9 |
| Race (NIH/OMB)(Participants) | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot | Parents/Guardians of Hospitalized Children Who Use Paro Robot | Parents/Guardians of Hospitalized Children Who do Not Use Paro Robot | Total |
|---|---|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 | 0 | 0 |
| Asian | 0 | 0 | 0 | 0 | 0 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 | 0 | 0 |
| Black or African American | 1 | 1 | 1 | 1 | 4 |
| White | 10 | 10 | 11 | 11 | 42 |
| More than one race | 0 | 0 | 0 | 0 | 0 |
| Unknown or Not Reported | 1 | 3 | 0 | 1 | 5 |
| Region of Enrollment(participants) | Physical and Occupational Therapy With Paro Robot | Physical and Occupational Therapy Without Paro Robot | Parents/Guardians of Hospitalized Children Who Use Paro Robot | Parents/Guardians of Hospitalized Children Who do Not Use Paro Robot | Total |
|---|---|---|---|---|---|
| United States | 12 | 14 | 12 | 13 | 51 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Apr 2022 to primary completion in Jan 2025, 33 months.
Results were first posted in Oct 2026, 1 year 9 months after primary completion.
Of 207 non-industry interventional studies with no phase under Precursor Cell Lymphoblastic Leukemia-Lymphoma, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 66. This study's 33 months is close to that.
Counting every sponsor, half of 214 studies reached it within 32 months; a quarter within 12 and three quarters within 66.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Precursor Cell Lymphoblastic Leukemia-Lymphoma →